Accendra Health Inc (ACH)vsHenry Schein Inc (HSIC)
ACH
Accendra Health Inc
$0.23
+14.72%
HEALTHCARE · Cap: $18.07M
HSIC
Henry Schein Inc
$84.96
+0.84%
HEALTHCARE · Cap: $9.63B
Smart Verdict
WallStSmart Research — data-driven comparison
Henry Schein Inc generates 414% more annual revenue ($13.60B vs $2.65B). HSIC leads profitability with a 3.0% profit margin vs -11.4%. ACH appears more attractively valued with a PEG of 0.70. HSIC earns a higher WallStSmart Score of 53/100 (C-).
ACH
Hold44
out of 100
Grade: D
HSIC
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+69.2%
Fair Value
$7.73
Current Price
$0.23
$7.50 discount
Margin of Safety
+47.2%
Fair Value
$154.78
Current Price
$84.96
$69.82 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Growing faster than its price suggests
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -198.4% — below average capital efficiency
Expensive relative to growth rate
Moderate valuation
3.0% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : ACH
The strongest argument for ACH centers on Debt/Equity, PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.
Bull Case : HSIC
HSIC has a balanced fundamental profile.
Bear Case : ACH
The primary concerns for ACH are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, P/E Ratio, Profit Margin. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
ACH profiles as a turnaround stock while HSIC is a value play — different risk/reward profiles.
ACH carries more volatility with a beta of 1.57 — expect wider price swings.
HSIC is growing revenue faster at 6.7% — sustainability is the question.
HSIC generates stronger free cash flow (196M), providing more financial flexibility.
Bottom Line
HSIC scores higher overall (53/100 vs 44/100). ACH offers better value entry with a 69.2% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accendra Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?